Helius Medical Technologies Announces First Three Subjects Enrolled in Canadian Multiple Sclerosis Feasibility Study

Helius Medical Technologies announced the enrollment of the first three subjects in the Multiple Sclerosis feasibility study at the Montreal Neurological Institute and Hospital and Concordia’s PERFORM Center.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1Dvv8gl

via IFTTT